Study examines attitudes toward long-acting injectable HIV therapy among women

A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection—including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs. Currently, most HIV therapies for treatment and prevention (pre-exposure prophylaxis, PrEP) necessitate […]

Continue Reading